Cargando…
Recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse
BACKGROUND: The scientific validity of the European Society of Cardiology’s (ESC) infective endocarditis (IE) guidelines limiting provision of prophylactic antibiotics (AP) only to patients having cardiac anomalies (e.g., prosthetic valves) believed to place them at “high risk” of adverse events whe...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medicina Oral S.L.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635622/ https://www.ncbi.nlm.nih.gov/pubmed/37330961 http://dx.doi.org/10.4317/medoral.25984 |
_version_ | 1785146344364572672 |
---|---|
author | Friedlander, Arthur H Couto-Souza, Paulo H |
author_facet | Friedlander, Arthur H Couto-Souza, Paulo H |
author_sort | Friedlander, Arthur H |
collection | PubMed |
description | BACKGROUND: The scientific validity of the European Society of Cardiology’s (ESC) infective endocarditis (IE) guidelines limiting provision of prophylactic antibiotics (AP) only to patients having cardiac anomalies (e.g., prosthetic valves) believed to place them at “high risk” of adverse events when undergoing high risk dental procedures (HRDP) is unclear. MATERIAL AND METHODS: A systematic review of studies conducted between 2017 and 2022 and catalogued in the PubMed database was undertaken to ascertain if this edict was associated with changes in IE incidence, development of infection in unprotected cardiac anomalies, developing infection and resultant adverse clinical outcomes. RESULTS: Retrieved were 19 published manuscripts, however of these, 16 were excluded because they did not bare upon the issues of concern. Among the three studies eligible for review were those in the Netherlands, Spain, and England. The results of the Dutch study denoted a significant increase in the incidence of IE cases over the projected historical trend (rate ratio: 1327, 95% CI 1.205-1.462; p<0.001) after the introduction of the ESC guidelines. The findings from the Spanish study evidenced the uniquely high in-hospital IE associated fatality rates suffered by patients having bicuspid aortic valves (BAV); 5.6% or mitral valve prolapse (MVP); 10%. The British study provided evidence that the incidence of fatal IE infection was significantly greater among an “intermediate risk” cohort of patients, (a group likely including those with BAC and MVP for which the ESC guidelines don’t recommend AP), than among “high risk” patients (P = 0.002). CONCLUSIONS: Patients having either a BAV or MVP are at significant risk of developing IE and suffering serious sequelae including death. The ESC guidelines must reclassify these specific cardiac anomalies into the “high risk” category so that AP are recognized as being needed prior to provision of HRDP. Key words:Infective endocarditis, antibiotic prophylactic, dentistry. |
format | Online Article Text |
id | pubmed-10635622 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Medicina Oral S.L. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106356222023-11-15 Recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse Friedlander, Arthur H Couto-Souza, Paulo H Med Oral Patol Oral Cir Bucal Review BACKGROUND: The scientific validity of the European Society of Cardiology’s (ESC) infective endocarditis (IE) guidelines limiting provision of prophylactic antibiotics (AP) only to patients having cardiac anomalies (e.g., prosthetic valves) believed to place them at “high risk” of adverse events when undergoing high risk dental procedures (HRDP) is unclear. MATERIAL AND METHODS: A systematic review of studies conducted between 2017 and 2022 and catalogued in the PubMed database was undertaken to ascertain if this edict was associated with changes in IE incidence, development of infection in unprotected cardiac anomalies, developing infection and resultant adverse clinical outcomes. RESULTS: Retrieved were 19 published manuscripts, however of these, 16 were excluded because they did not bare upon the issues of concern. Among the three studies eligible for review were those in the Netherlands, Spain, and England. The results of the Dutch study denoted a significant increase in the incidence of IE cases over the projected historical trend (rate ratio: 1327, 95% CI 1.205-1.462; p<0.001) after the introduction of the ESC guidelines. The findings from the Spanish study evidenced the uniquely high in-hospital IE associated fatality rates suffered by patients having bicuspid aortic valves (BAV); 5.6% or mitral valve prolapse (MVP); 10%. The British study provided evidence that the incidence of fatal IE infection was significantly greater among an “intermediate risk” cohort of patients, (a group likely including those with BAC and MVP for which the ESC guidelines don’t recommend AP), than among “high risk” patients (P = 0.002). CONCLUSIONS: Patients having either a BAV or MVP are at significant risk of developing IE and suffering serious sequelae including death. The ESC guidelines must reclassify these specific cardiac anomalies into the “high risk” category so that AP are recognized as being needed prior to provision of HRDP. Key words:Infective endocarditis, antibiotic prophylactic, dentistry. Medicina Oral S.L. 2023-11 2023-06-18 /pmc/articles/PMC10635622/ /pubmed/37330961 http://dx.doi.org/10.4317/medoral.25984 Text en Copyright: © 2023 Medicina Oral S.L. https://creativecommons.org/licenses/by/2.5/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Friedlander, Arthur H Couto-Souza, Paulo H Recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse |
title | Recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse |
title_full | Recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse |
title_fullStr | Recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse |
title_full_unstemmed | Recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse |
title_short | Recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse |
title_sort | recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635622/ https://www.ncbi.nlm.nih.gov/pubmed/37330961 http://dx.doi.org/10.4317/medoral.25984 |
work_keys_str_mv | AT friedlanderarthurh recentinfectiveendocarditisresearchfindingssuggestdentistsprescribeprophylacticantibioticsforpatientshavingabicuspidaorticvalveormitralvalveprolapse AT coutosouzapauloh recentinfectiveendocarditisresearchfindingssuggestdentistsprescribeprophylacticantibioticsforpatientshavingabicuspidaorticvalveormitralvalveprolapse |